From: MR diffusion versus MR perfusion in patients with ovarian tumors; how far could we get?
Pathological diagnosis | P value | |||||
---|---|---|---|---|---|---|
Benign (I) | Borderline (II) | Malignant (III) | ||||
N = 18 | N = 4 | N = 25 | ||||
MRE | 0.577 | |||||
Range | (50–190.8) | (45–200.5) | (39.7–141) | |||
Mean ± SD | 118.8 ± 49.8 | 118.2 ± 80.6 | 110.5 ± 31.3 | I vs II | I vs III | II vs III |
Median | 139 | 113.6 | 118.5 | |||
0.966 | 0.284 | 0.752 | ||||
SI max | <0.001* | |||||
Range | (66–1674.6) | (1620.5–2630.5) | (1299.6–3729) | |||
Mean ± SD | 560.8 ± 492.7 | 1949.8 ± 461.2 | 1973.1 ± 572.6 | |||
I vs II | I vs III | II vs III | ||||
Median | 513.4 | 1774.1 | 1900.2 | |||
0.003* | <0.001* | 0.950 | ||||
WIR | <0.001* | |||||
Range | (1.7–76.2) | (11.6–113.2) | (14–33.5) | |||
Mean ± SD | 15.3 ± 15.7 | 41.6 ± 48 | 23.2 ± 5.4 | I vs II | I vs III | II vs III |
Median | 13 | 20.9 | 22 | |||
0.125 | <0.001* | 0.704 | ||||
WOR | ||||||
Range | (0.6–6) | (1–7.5) | (6.5–17.2) | <0.001* | ||
Mean ± SD | 3.7 ± 1.9 | 3.1 ± 3 | 10.7 ± 3.1 | |||
Median | 4.3 | 1.9 | 9.8 | I vs II | I vs III | II vs III |
0.670 | <0.001* | 0.003* |